Abstract
Natural products isolated from marine invertebrate fauna and their associated microbial communities are globally recognized as potentially rich sources of new pharmaceuticals, especially anti-cancer agents. With the exception of southern Africa, Africa’s marine biodiversity is generally poorly described especially from marine biota found in the more remote and largely inaccessible areas along Africa’s 30,500-km-long coastline. Over the last four decades, bioprospecting for new medicinal compounds from African marine organisms has generally been confined to the marine invertebrate communities residing off the more accessible southern African coast. A total of 18 South African marine natural products have been patented for their anti-cancer activity with the marine tube worm metabolite cephalostatin 1 and a synthetic analogue of the sponge metabolite hemiasterlin, showing the greatest promise for new drug development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BMS:
-
Bristol-Myers Squibb
- HIF-1:
-
Hypoxia-inducible factor-1
- NCI:
-
National Cancer Institute
- ORI:
-
Oceanographic Research Institute
- Rhodes:
-
Rhodes University
- SCC:
-
Squamous cell carcinoma
- SCOC:
-
Squamous cell oesophageal cancer
- SIO:
-
Scripps Institution of Oceanography
- SKB:
-
SmithKline Beecham
- STS:
-
Soft tissue sarcoma
References
Cragg GM, Grothaus PG et al (2009) Impact of natural products on developing new anti-cancer agents. Chem Rev 109:3012–3043
Fusetani N (2010) Biotechnological potential of marine natural products. Pure Appl Chem 82:17–26
Glaser KB, Mayer AMS (2009) A renaissance in marine pharmacology: from preclinical curiosity to clinical reality. Biochem Pharmacol 78:440–448
Sashidhara KV, White KN et al (2009) A selective account of effective paradigms and significant outcomes in the discovery of inspirational marine natural products. J Nat Prod 72:588–603
Cuevas C, Francesch A (2009) Development of Yondelis (trabectedin, ET-743). A semisynthetic process solves the supply problem. Nat Prod Rep 26:322–337
European Science Foundation (2010) Position Paper 15. Marine biotechnology: a new vision and strategy for Europe. http://www.esf.org/index.php?eID=tx_nawsecuredl&u=0&file=fileadmin/be_user/research_areas/marine/pdf/Publications/MBPP15_MarineBiotechnology.pdf&t= 1305543601&hash=63880103a556f163639f0be4178d1512. Accessed 23 May 2010
Andersen RJ, Williams DE (2000) Pharmaceuticals from the sea. In: Hester R, Harrison R (eds) Chemistry in the marine environment, 13th edn. RSC Press, Cambridge
Jarvis LM (2009) Building brick by brick. Chem Eng News 87:13–20
Mulholland DA, Drewes SE (2004) Global phytochemistry: indigenous medicinal chemistry on track in southern Africa. Phytochemistry 65:769–782
Branch ML, Branch GM (1992) The living shores of Southern Africa. Struik, Cape Town
Branch GM, Griffiths CL et al (1994) Two oceans. David Philip, Cape Town
Davies-Coleman MT (2005) Bioactive natural products from southern African marine invertebrates. In: Atta-ur-Rahman (ed) Studies in natural products chemistry, 32nd edn. Elsevier, Amsterdam
Pettit GR, Inoue M et al (1988) Isolation and structure of the powerful cell-growth inhibitor cephalostatin-1. J Am Chem Soc 110:2006–2007
Pettit GR, Herald CL et al (1993) Isolation and structure of the powerful human cancer cell-growth inhibitors spongistatins 4 and 5 from an African Spirastrella-Spinispirulifera (Porifera) 1. J Chem Soc Chem Comm 1805–1807
Lopez-Anton N, Rudy A et al (2006) The marine product cephalostatin 1 activates an endoplasmic reticulum stress-specific and apoptosome-independent apoptotic signaling pathway. J Biol Chem 281:33078–33086
Rudy A, Lopez-Anton N et al (2008) The cephalostatin way of apoptosis. J Nat Prod 71:482–486
Fortner KC, Kato D et al (2010) Enantioselective synthesis of (+)-cephalostatin 1. J Am Chem Soc 132:275–280
Fenical W, Jensen P et al (2003) New anticancer drugs from cultured and collected marine organisms. Pharm Biol 41:6–14
Moser BR (2008) Review of cytotoxic cephalostatins and ritterazines: isolation and synthesis. J Nat Prod 71:487–491
Lee S, LaCour TG et al (2009) Chemistry of trisdecacyclic pyrazine antineoplastics: the cephalostatins and ritterazines. Chem Rev 109:2275–2314
Proksch P, Edrada-Ebel R et al (2003) Drugs from the sea – opportunities and obstacles. Mar Drugs 1:5–17
LaCour TG, Guo C et al (1998) Interphylal product splicing: the first total syntheses of cephalostatin 1, the north hemisphere of ritterazine G, and the highly active hybrid analog, ritterostatin GN1N. J Am Chem Soc 120:692–707
Williams GC (1993) Coral reef octocorals – an illustrated guide to the soft corals, sea fans and sea pens inhabiting the coral reefs of northern Natal. Durban Natural Science Museum, Durban
Blunt JW, Copp BR et al (2011) Marine natural products. Nat Prod Rep 28:196–268
Rudi A, Goldberg I et al (1993) Sodwanones A-C, three new triterpenoids from a marine sponge. Tetrahedron Lett 34:3943–3944
Rudi A, Kashman Y et al (1994) Sodwanones A-F, new triterpenoids from the marine sponge Axinella weltneri. J Nat Prod 57:1416–1423
Rudi A, Goldberg I et al (1995) Sodwanones G, H, and I, new cytotoxic triterpenes from a marine sponge. J Nat Prod 58:1702–1712
Rudi A, Kashman Y et al (1996) Cytotoxic triterpenes from a marine sponge. WO Patent 9701334
Kashman Y, Koren-Goldshlager G et al (1999) Halitulin, a new cytotoxic alkaloid from the marine sponge Haliclona tulearensis. Tetrahedron Lett 40:997–1000
Kashman Y, Koren-Goldshlager G et al (1999) Cytotoxic alkaloids including halitulin, isolation from Haliclona tulearensis, and antitumor activity. WO Patent 2000020411
Talpir R, Benayahu Y et al (1994) Hemiasterlin and geodiamolide TA; two new cytotoxic peptides from the marine sponge Hemiasterella minor (Kirkpatrick). Tetrahedron Lett 35:4453–4456
Kashman Y, Gravalos DG (1995) Hemiasterlin and geodiamolide TA from the sponge Hemiasterella minor, and methods using them for treatment of tumors. US Patent 5661175
Anderson HJ, Coleman JE et al (1997) Cytotoxic peptides hemiasterlin, hemiasterlin A, and hemiasterlin B include mitotic arrest and abnormal spindle formation. Cancer Chemother Pharmacol 39:223–226
Kingston DGI (2009) Tubulin-interactive natural products as anticancer agents. J Nat Prod 72:507–515
Nieman JA, Coleman JE et al (2003) Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues. J Nat Prod 66:183–199
Kuznetsov G, TenDyke K et al (2009) Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin. Mol Cancer Ther 8:2852–2860
Vashist YK, Tiffon C et al (2006) Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin. World J Gastroenterol 12:6771–6778
Hadaschik BA, Adomat H et al (2008) Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin. Clin Cancer Res 14:1510–1518
Hadaschik BA, Ettinger S et al (2008) Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. Int J Cancer 122:2368–2376
Rudi A, Ketzinel S et al (1995) Antheliatin and zahavins A and B, three new cytotoxic xenicane diterpenes from two soft corals. J Nat Prod 58:1581–1586
Rudi A, Kashman Y et al (1996) Reef-inhabiting soft coral cytotoxic xenicane diterpenes with anti-tumor activities, Anthelia glauca antheliatin and Alcyonium aurea zahavin a and zahavin b. WO Patent 9632388
Keyzers RA, Daoust J et al (2008) Autophagy-modulating aminosteroids isolated from the sponge Cliona celata. Org Lett 10:2959–2962
Keyzers RA, Gray CA et al (2006) Malonganenones A-C, novel tetraprenylated alkaloids from the Mozambique gorgonian Leptogorgia gilchristi. Tetrahedron 62:2200–2206
Cockburn IL, Pesce E et al (2011) Screening for small molecule modulators of Hsp70 chaperone activity using protein aggregation suppression assays: inhibition of the plasmodial chaperone PfHsp70-1. Biol Chem 392:431–438
Dai J, Fishback JA et al (2006) Sodwanone and yardenone triterpenes from a South African species of the marine sponge Axinella inhibit hypoxia-inducible factor-1 (HIF-1) activation in both breast and prostate tumor cells. J Nat Prod 69:1715–1720
Hendricks D, Parker MI (2002) Oesophageal cancer in Africa. IUBMB Life 53:263–268
Stoner GD, Wang LS et al (2007) Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharm 224:337–349
Pickens A, Orringer MB (2003) Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg 76:S1367–S1369
Mqoqi N, Keller P et al (2003) Incidence and geographical distribution of histologically diagnosed cancer in South Africa, 1996–1997. National Cancer Registry of South Africa, South African Institute for Medical Research, Johannesburg
Tew WP, Kelsen DP et al (2005) Targeted therapies for esophageal cancer. Oncologist 10:590–601
Lordick F, Stein HJ et al (2004) Neoadjuvant therapy for oesophagogastric cancer. Brit J Surg 91:540–551
Scheithauer W (2004) Esophageal cancer: chemotherapy as palliative therapy. Ann Oncol 15:97–100
Whibley CE, Keyzers RA et al (2005) Antiesophageal cancer activity from southern African marine organisms. Ann N Y Acad Sci 1056:405–412
Whibley CE, McPhail KL et al (2007) Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones. Mol Cancer Ther 6:2535–2543
Li CH, Chen XS et al (2005) The first total synthesis of triprenylquinone and hydroquinones. Chin Chem Lett 16:1024–1026
Davies-Coleman MT, Froneman W et al (2005) Anti-oesophageal cancer activity in extracts of deep-water Marion Island sponges. S Afr J Sci 101:489–490
van Wyk AWW, Gray CA et al (2008) Bioactive metabolites from the South African marine mollusk Trimusculus costatus. J Nat Prod 71:420–425
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Davies-Coleman, M.T., Sunassee, S.N. (2012). Marine Bioprospecting in Southern Africa. In: Chibale, K., Davies-Coleman, M., Masimirembwa, C. (eds) Drug Discovery in Africa. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28175-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-28175-4_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28174-7
Online ISBN: 978-3-642-28175-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)